Contract manufacturing service for liquid media compliant with GMP for pharmaceuticals.
Domestic manufacturing, stable procurement, transportation cost reduction | Contract manufacturing of liquid media compliant with GMP.
In the pharmaceutical industry, particularly in the quality control department, the quality of the liquid media used for cell culture is a crucial factor that influences the safety and efficacy of products. Media manufactured in a GMP-compliant environment minimizes the risk of contamination and enhances the reliability of test results. Our services provide high-quality liquid media through a GMP-compliant manufacturing environment and a stringent quality control system, supporting your quality management framework. 【Usage Scenarios】 - Procurement of media in the cell culture process - Ensuring media quality in the quality control department - Supply of media in the regenerative medicine field 【Benefits of Implementation】 - Quality assurance through GMP compliance - Increased efficiency in manufacturing processes due to stable supply - Reduction of contamination risks
basic information
**Features** - Manufacturing environment compliant with GMP - Production line capable of handling small quantities and a variety of products - Strict raw material management - Aseptic filling into containers tailored to customer requirements - Consultation available for implementation audits **Our Strengths** We are a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Ltd., merging high-quality amino acid-based culture media raw materials with advanced production technology to provide contract manufacturing of clinical culture media necessary for regenerative medicine.
Price information
Please contact us separately.
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（3）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.